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Abstract
Background: Plexiform angiomyxoid myofibroblastic tumor (PAMT), also known as plexiform fibromyxoma, is a rare distinctive
benign intramural tumor, typical of gastric antrum, commonly causing mucosal ulceration with upper gastrointestinal bleeding and
anemia, effectively treated by complete surgical resection usually accomplished by distal gastrectomy.
Methods and Results: We herein report a 47-year-old man presenting with a syncopal episode, regurgitation and epigastric
discomfort, bearing a gastric antral myxoid plexiform tumor positive fora-smoothmuscle actin, vimentin and, partially, for caldesmon,
desmin, and CD10; CD117, DOG1, CD34, S100, CAM5.2, CK20, CK7, EMA, p53, CDX2, chromogranin A, synaptophysin,
anaplastic lymphoma kinase, Melan-A, and HMB-45 were all negative. All these features are typical of PAMT. Of note, focal positivity
for AE1/AE3 and pan-CK KL1 was also present.
Conclusions: The finding of a focal keratin expression in PAMT contributes to enlarge the immunophenotypic spectrum of this
tumor type and is relevant for avoiding presurgical misdiagnoses which could ultimately lead to inappropriate overtreatment of
patients with PAMT.
Abbreviations: CK = cytokeratin, IHC = immunohistochemistry, PAMT = plexiform angiomyxoid myofibroblastic tumor.
Keywords: differential diagnosis, histopathology, immunohistochemistry, plexiform angiomyxoid myofibroblastic tumor, plexiform
fibromyxoma
1. Introduction exceptional extragastric cases have been described in thePlexiform angiomyxoid myofibroblastic tumor (PAMT), also
known as plexiform fibromyxoma, is a rare mesenchymal
neoplasm, recently characterized by Takahashi et al[1] and
Miettinen et al[2] following reports from the preimmunohisto-
chemistry (IHC) era probably concerning the same entity.[3–7] At
the best of our knowledge, 59 cases of PAMT (including the
present case and 2 uncertain ones) have been reported so far
(Table 1).[1,2,8–33] This tumor affects both sexes with a wide age
span (7–75 years). It typically arises in the gastric antrum;Editor: Bulent Kantarceken.
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esophagus, duodenum, jejunum, gallbladder and, possibly, in
the colon.[22,26,27,30,33] PAMT characteristically features a
plexiform architecture, with myxoid nodules located in the
gastric muscularis propria, often ulcerating the overlyingmucosa,
composed of ovoid cells with indistinct cytoplasm; a prominent
capillary network is invariably present. At IHC, PAMT is positive
for a-smooth muscle actin (a-SMA) and, sometimes, for desmin
and/or caldesmon, consistently with myofibroblastic differentia-
tion. KIT and PDGFRA are wild type. PAMT pursues a benign
course following complete excision by distal gastrectomy.
Despite PAMT typical location and plexiform architecture, its
rarity and rather vague histology, in a context usually suggestive
for GIST (the most frequent gastric mesenchymal tumor[34]), can
hinder bioptic attempts to achieve a correct preoperative
diagnosis. The latter can be further confused by the exceptional
feature we herein describe in a PAMT: cytokeratin expression.
2. Case report
A 47-year-old man presented with a syncopal episode following
several months of regurgitation and worsening epigastric
discomfort. Routine laboratory tests, electrocardiogram, and
chest X-ray were unremarkable. Endoscopy showed a subepi-
thelial lesion in the gastric antrum; the overlying mucosa was
focally ulcerated. Endoscopic ultrasound-fine needle tissue
acquisition[35] did not yield diagnostic material. Contrast-
enhanced computed tomography showed an enhancing 6.5cm
mass bulging into the antral cavity and focally involving the
omentum. A distal gastrectomy was performed. Currently, at
10 months’ follow-up, the patient is well.
Patient’s informed consent was obtained for publication of this
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3
and followed standard laboratory procedures. This case is not
part of a clinical trial or research study. The declaration of
Helsinki is thus not applicable and approval of the ethics
committee is not required.
Sections from formalin-fixed, paraffin-embedded tumor were
stained with hematoxylin and eosin or alcian blue. Pathology
revealed a 60-mm reddish gelatinous lobulated antral mass
(Fig. 1A), involving submucosa, muscularis propria, and
subserosa; the overlying mucosa was ulcerated. Histology
showed a plexiform tumor composed of cells with ovoid nuclei,
indistinct cytoplasms and, occasionally, clear halos, in a myxoid,
alcian-positive matrix, sometimes with tiny collagen bundles,
with arborizing capillary vessels (Fig. 1B and C). Tumor cells
were positive for a-SMA (Fig. 1D), vimentin (not shown) and,
partially, for caldesmon (Fig. 1E), desmin andCD10 (not shown);
moreover, focal positivity for AE1/AE3 (Fig. 1F) and pan-CK
KL1 (not shown) was detected. CD117, DOG1, CD34, S100,
CAM5.2, CK20, CK7, EMA, p53, CDX2, chromogranin A,
synaptophysin, Melan-A, HMB-45, and anaplastic lymphoma
kinase (ALK)were all negative (not shown).KIT (exons 9, 11, 13,
and 17) and PDGFRA (exons 12, 14, and 18), amplified using the
same primers and polymerase chain reaction conditions
described elsewhere,[35] were wild type. These findings rule out
GIST, the most common mesenchymal tumor of stomach,[34] and
carcinoma, because of both morphology and inconsistent
immunophenotype; conversely, they are typical of PAMT, with
the exception of the focal CK (AE1/AE3 and KL1) expression,
exceptional in this tumor type.
3. Discussion
In this study, we report the exceptional occurrence of CK
expression in a typical PAMT. PAMT, also known as plexiform
fibromyxoma, is a myofibroblastic tumor recently fully charac-
terized.[1,2] Probably the same tumor had been previously
signaled several times in the pre-IHC era.[3–7] At the best of
our knowledge, 59 PAMTs (including the present case and 2
uncertain ones) have been described in the literature
(Table 1).[1,2,8–33] With the caveat due to the limitations in both
number of cases and follow up, PAMT appears a benign entity; in
fact, neither metastases nor relapses after complete surgical
resection have been signaled so far. PAMT is capable of smooth
muscle differentiation, as shown by the possible focal expression
of caldesmon and desmin.[1,21,22,28]As such, PAMT can be
expected to occasionally express CKs, since both myofibroblastic
and smooth muscle tumors are known to be sometimes able to
express these markers.[36] A restrict number of mesenchymal
tumors (i.e., synovial sarcoma and epithelial sarcoma) display a
true epithelial differentiation, with expression of both low- and
high-molecular weight CK isoforms and of other epithelial
markers, such as desmoplakins and occludin. Unlike these
sarcomas, CK expression found in smooth muscle and
myofibroblastic tumors is anomalous and does not reflect
genuine epithelial differentiation, involving only a subset of
neoplastic cells, mostly with IHC staining limited to a portion
only of the cytoplasm, sometimes in a dot-like pattern.[37] This is
the case of the herein reported PAMT (Fig. 1F). Coherently with
the lack of a true epithelial differentiation, EMA IHC resulted
negative, as happened in all PAMTs previously tested for this
marker[10,11,13,18,19,27,30] with the exception of a focal positivity
in a single case reported in the Chinese literature.[20] The presence
of a hybrid epithelial–mesenchymal phenotype (so-called
“amphicrine pattern”) is a feature of epithelial-to-mesenchymal
Figure 1. Pathological findings of the resected mass. (A) The resected specimen revealed a 60mm lobulated intramural antral mass with a reddish gelatinous cut
surface. (B, C) Histology of the tumor showed a plexiform intramural neoplasm displaying an alcian-positive myxoid matrix, with an arborizing capillary network (B,
hematoxylin and eosin; C, alcian blue). (D–F) Immunohistochemistry of the tumor showed expression of a-smooth muscle actin (D) and partial positivity for
caldesmon (E) (note the positive control of the intensely stained muscularis propria—bottom in D, bottom right in E), and focal positivity for cytokeratins AE1/AE3,
sometimes with a perinuclear or a dot-like pattern (F).
Quero et al. Medicine (2016) 95:28 Medicineand mesenchymal-to-epithelial cell transitions (MET), phenome-
na which can be found either in organ development or tumors.
With regard to gastrointestinal (GI) mesenchymal tumors, MET
has been described in GISTs, apparently with a favorable
prognostic role.[38] Given the lack of aggressive behavior in the
hitherto reported PAMTs, there is no room for a similar
biological role of MET in these tumors.
The morphology of the herein reported PAMT (as happens
with PAMT as a whole) does not support a diagnosis of
carcinoma, although some carcinomas may show myxoid
features.[39] In particular, its typical discohesive architecture
excludes most carcinomas with the possible exceptions of poorly
cohesive gastric carcinoma and gastric metastasis from a lobular
breast cancer. However, the former is ruled out by the lack of
atypia in the overlying mucosal epithelium and the latter by the
clinical context of the reported tumor (lobular breast cancer is
very rare in males). Furthermore, both of these neoplasms are
excluded by the detected tumoral immunohistochemical profile.
PAMT must be distinguished from other mesenchymal tumors
which can be found in the GI tract. GISTs (which can display
myxoid or plexiform features) are typically CD117+ and
DOG1+, express CD34 in about 2/3 of cases and mostly bear
an activating mutation in either KIT or PDGFRA.[34] Inflamma-
tory fibroid polyps, although often arising in the gastric antrum,
rarely grow deeper than submucosa, typically feature CD34+
spindle cells arranged in an onion-skin pattern around blood
vessels, are rich in eosinophils and are often PDGRA mutant.[40]
Schwannomas, although often displaying areas with a loose4
texture (so-called “Antoni B areas”) and sometimes featuring
a plexiform architecture, often exhibit peripheral lymphoid
aggregates and are consistently intensely and diffusely S100+.
Inflammatory myofibroblastic tumors feature a relevant inflam-
matory infiltrate which, together with the loosely arranged
myofibroblasts in an edematous myxoid background, simulates
granulation tissue; moreover, about half of cases display
cytoplasmic positivity for ALK protein.[41] Abdominal des-
moid-type fibromatoses feature myofibroblasts arranged in long
sweeping bundles, set in a collagenous stroma and, although
sometimes showingmyxoid change, lack a plexiform architecture
and are mostly b-catenin positive at nuclear level.[42] Perhaps the
gastric mesenchymal tumor which can be more easily confused
with PAMT is myxoid leiomyoma, given its positivity for a-SMA,
desmin, and caldesmon; however, it usually arises in the cardias
or fundus, and is composed of cells with relatively abundant,
intensely eosinophilic cytoplasm, with blunt-ended nuclei and
intensely and diffusely desmin+ and caldesmon+.[43,44] In
females, PAMT must be distinguished from metastatic low-
grade endometrial stromal sarcoma (ESS); in fact, progesterone
receptor positivity has been exceptionally reported in 2
PAMTs,[15,20] while ESS displays CD10 positivity, can be
myxoid and can metastasize to the GI tract; a clinical history
negative for gynecological neoplasms and the lack of estrogen
and progesterone receptors exclude this entity.[11]Table 2
summarizes the differential diagnosis of PAMT.
Although the PAMT CK expression we report is thus not
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[20] Bi R, Yin W, Liu XL, et al. Plexiform angiomyxoid myofibroblastic
Quero et al. Medicine (2016) 95:28 Medicinenevertheless contributes to enlarge the known immunopheno-
typic spectrum of this tumor. In fact, at the best of our knowledge,
all PAMTs so far immunohistochemically tested for CK
expression resulted negative[1,2,11,13,15,16,18,22,24,28,29] with the
exception of the report of focal positivity in a single case from the
Chinese literature.[20] But, beyond its descriptive value, the
awareness of a possible CK positivity in PAMT is relevant for
avoiding possible misinterpretations of PAMT biopsies, especial-
ly when dealing with suboptimal amounts of tissue. In fact, under
these circumstances, there is the risk of misdiagnosing PAMT as
poorly cohesive gastric carcinoma, a neoplasm which can be
extensively infiltrative in spite of mucosal lesions endoscopically
elusive, potentially leading to dramatic consequences in the
management of patients with PAMT.
In conclusion, we demonstrate the possible expression of CK in
PAMT, an exceptional finding which, although not surprising
considering the tissue lineage of this tumor, can be very relevant
in the routine practice of pathologists for avoiding possible
misdiagnoses with heavy clinical consequences.References
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